Mengmeng Li
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Pharmacodynamics and mechanisms of triterpene components from the leaves of Astragalus mongholicus Bunge in the treatment of Alzheimer's disease.
Journal: Natural product research
Published: May 15, 2026
MDH1 K298 succinylation stabilizes redox homeostasis to protect against cardiac ferroptosis in ischemia-reperfusion injury.
Journal: Journal of advanced research
Published: March 08, 2026
Polygonatum Sibiricum polysaccharide ameliorates Alzheimer's disease by alleviating cuproptosis and activating the PI3K/AKT signaling pathway.
Journal: Journal of ethnopharmacology
Published: January 01, 2026
Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer's disease.
Journal: Ageing research reviews
Published: November 28, 2025
Metabolites of Food Bioactives Targeting Post-Translational Modifications in Cardiovascular Diseases: Mechanisms and Therapeutic Potential.
Journal: Journal of agricultural and food chemistry
Published: October 28, 2025
Novel Neuroprotective Phytochemicals From the Roots of Arnebia euchroma: Isolation and Biological Evaluation.
Journal: Chemistry & biodiversity
Published: July 16, 2025
Corrigendum to "Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities" [Pharmacol. Res. 2025 May 27:107802].
Journal: Pharmacological research
Published: June 06, 2025
Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities.
Journal: Pharmacological research
Published: March 30, 2025
Saponins from Astragalus membranaceus (Fisch.) Bge Alleviated Neuronal Ferroptosis in Alzheimer's Disease by Regulating the NOX4/Nrf2 Signaling Pathway.
Journal: Journal of agricultural and food chemistry
Published: March 22, 2025
The total withanolides from the leaves of Datura stramonium L. Improves Alzheimer's disease pathology by restraining neuroinflammation through NLRP3/IL-1β/IL1R1/TOM 1 pathway.
Journal: International immunopharmacology
Published: November 14, 2024
Last Updated: 09/26/2026